Sibold William John 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Sibold William John
DirectorPresident and CEO
Transactions
- Award
Performance Restricted Stock Units
2023-09-11+50,000→ 50,000 total→ Common Stock (50,000 underlying) - Award
Common Stock
2023-09-11+50,000→ 50,000 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest as to 25% of the shares on each of September 8, 2024, September 8, 2025, September 8, 2026 and September 8, 2027, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]Represents a grant of performance-based restricted stock units, which represent the contingent right to receive a number of shares of the Issuer's common stock that is between 0% and 300% of the target amount of units, depending on the Issuer's achievement of significant sustained stock price appreciation hurdles over a five-year period and which may settle on the 4th, 5th and 6th anniversaries of the grant date, depending on the date of vesting and performance level achieved. The number of shares of common stock reported assumes a target that corresponds to a 100% payout level.